Global policy review of antiretroviral therapy eligibility criteria for treatment and prevention of HIV and tuberculosis in adults, pregnant women, and serodiscordant couples

Journal of Acquired Immune Deficiency Syndromes

Volumn 62, Issue 3, 2013, Pages

  Gupta, Somya ^a   Granich, Reuben ^a   Suthar, Amitabh B ^a   Smyth, Caoimhe ^a   Baggaley, Rachel ^a   Sculier, Delphine ^a   Date, Anand ^b   Desai, Mitesh A ^b   Lule, Frank ^a   Raizes, Elliot ^b   Blanc, Leopold ^a   Hirnschall, Gottfried ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Antiretroviral therapy; CD4; Heterosexual transmission; Opportunistic infections; Prevention of sexual transmission; Tuberculosis

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; CD4 LYMPHOCYTE COUNT; HEALTH CARE POLICY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MALE HOMOSEXUAL; ORGANIZATION AND MANAGEMENT; PRACTICE GUIDELINE; PREGNANT WOMAN; PRIORITY JOURNAL; PROSTITUTION; SYSTEMATIC REVIEW; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

EID: 85027957518     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31827e4992     Document Type: Article

References (28)

1. De Cock KM, Jaffe HW, Curran JW. Reflections on 30 years of AIDS. Emerg Infect Dis. 2011;17:1044-1048.
2. UNAIDS. Together We Will End AIDS. Geneva, Switzerland: UNAIDS; 2012. Available at: http://www.unaids.org/en/media/unaids/contentassets/documents/ epidemiology/2012/20120718-togetherwewillendaids-en.pdf. Accessed August 1, 2011.
3. Montaner JS, Hogg R, Wood E, et al. The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet. 2006;368:531-536.
4. Attia S, Egger M, Muller M, et al. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and metaanalysis. AIDS. 2009;23:1397-1404.
5. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000;342:921-929.
6. Girardi E, Antonucci G, Vanacore P, et al. Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection. AIDS. 2000;14:1985-1991.
7. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011;365:493-505.
8. Suthar AB, Lawn SD, Del Amo J, et al. Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and metaanalysis. PLoS Med 2012;9:e1001270.
9. WHO. Guidelines Review Committee (GRC). Geneva, Switzerland: WHO; 2010. Available at: http://www.who.int/kms/guidelines-review-committee/en/index.html Accessed August 1, 2011.
10. WHO. Antiretroviral Therapy for HIV Infection in Adults and Adolescents. Geneva, Switzerland: WHO; 2010. Available at: http://whqlibdoc.who.int/ publications/2010/9789241599764-eng.pdf Accessed July 1, 2011.
11. WHO. Guidance on Couples HIV Testing and Counselling, Including Antiretroviral Therapy for Treatment and Prevention in Serodiscordant Couples: Recommendations for a Public Health Approach. Geneva, Switzerland: WHO; 2012. Available at: http://whqlibdoc.who.int/publications/2012/9789241501972-eng.pdf Accessed August 1, 2012.
12. WHO. Programmatic Update-Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants, Executive Summary. Geneva, Switzerland: WHO; 2012. Available at: http://www.who.int/hiv/pub/pmtct- update.pdf Accessed August 1, 2012.
13. UNAIDS. Getting to Zero 2011-2015 Strategy. Geneva, Switzerland: UNAIDS; 2010. Available at: http://www.unaids.org/en/media/unaids/contentassets/ documents/unaidspublication/2010/JC2034-UNAIDS- Strategy-en.pdf. Accessed August 1, 2011.
14. WHO. Online Database of National HIV and TB Guidelines; Geneva, Switzerland: WHO; 2011. Available at: http://www.who.int/hiv/pub/national- guidelines/en/index.html Accessed July 1, 2011.
15. AIDSTAR-One. National Treatment Guidelines. AIDSTAR-One. Available from: http://www.aidstar-one.com/focus-areas/treatment/resources/national-treatment- guidelines. Accessed July 1, 2011.
16. GFMER. HIV/AIDS: Guidelines, Reviews, Statements, Recommendations, Standards. Geneva, Switzerland: GFMER. Available at: http://www.gfmer.ch/ Guidelines/HIV-AIDS/HIV-AIDS-mt.htm Accessed August 1, 2011.
17. Wilsdon T, Attridge J, Sauri L, et al. Evidence on Access to Essential Medicines for Treatment of HIV/AIDS. London, United Kingdom: Charles River Associates; 2011. Available at: http://www.ifpma.org/fileadmin/content/ Publication/2011/CRA-Access-to-Essential-Medicines-HIVAIDS-October2011.pdf Accessed May 1, 2012.
18. UNAIDS. AIDS at 30: Nations at the Cross Roads. UNAIDS: Geneva, Switzerland; 2011. Available at: http://www.unaids.org/unaids-resources/ aidsat30/aids-at-30.pdf Accessed July 1, 2012.
19. Barre-Sinoussi F, Chermann JC, Rey F, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science. 1983;220:868-871.
20. WHO. HIV/TB Facts 2011. Geneva, Switzerland: WHO; 2011. Available at: http://www.who.int/hiv/topics/tb/hiv-tb-factsheet-june-2011.pdf Accessed June 1, 2012.
21. Siegfried N, Uthman OA, Rutherford GW. Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults. Cochrane Database Syst Rev. 2010:CD008272.
22. Walensky RP, Wood R, Ciaranello AL, et al. Scaling up the 2010 World Health Organization HIV Treatment Guidelines in resource-limited settings: a model-based analysis. PLoS Med 2010;7:e1000382.
23. Montaner JS, Lima VD, Barrios R, et al. Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet. 2010;376:532-539.
24. Kitahata MM, Gange SJ, Abraham AG, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med 2009;360:1815-1826.
25. Sterne JA, May M, Costagliola D, et al. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet. 2009;373:1352-1363.
26. The HIV-CAUSAL Collaboration. When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining conditions in HIV-infected persons in developed countries. Ann Intern Med 2011;154:509-515.
27. United Nations. Political Declaration on HIV and AIDS: Intensifying Our Efforts to Eliminate HIV and AIDS 2011. New York, NY: UN General Assembly; 2011. Available at: http://www.unaids.org/en/media/unaids/contentassets/documents/ document/2011/06/20110610-un-a-res-65-277-en.pdf Accessed June 1, 2012.
28. National Center for AIDS/STD Control and Prevention (NCAIDS), China CDC, and British Columbia Centre for Excellence in HIV/AIDS. Treatment as Prevention Strategy in China. Vancouver, Canada: National Center for AIDS/STD Control and Prevention (NCAIDS), China CDC, and British Columbia Centre for Excellence in HIV/AIDS (BCCfE). Available at: http://www.cfenet.ubc.ca/news/releases/china- implements-bc-cfe%E2%80%99s-treatment-preventionstrategy- country%E2%80%99snational-hivaids-polAccessed June 1, 2012.